Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Craig

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 25, 2020
Tumor-targeted dose escalation for localized prostate cancer using MR-guided HDR brachytherapy (HDR) or integrated VMAT (IB-VMAT) boost: Dosimetry, toxicity and health related quality of lifeNoelia Sanmamed, Jenny Lee, Alejandro Berlin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 1, 2022
Evaluation of dosimetric predictors of toxicity after IMRT with concurrent chemotherapy for anal cancerJelena Lukovic, Ali Hosni, Amy Liu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 25, 2017
Improved outcomes with dose escalation in localized prostate cancer treated with precision image-guided radiotherapyHamid Raziee, Fabio Y Moraes, Jure Murgic, et al.
European Urology Oncology|May 7, 2025
Patient-reported Quality of Life in PROFIT, a Phase 3 Randomized Clinical Trial Evaluating Moderately Hypofractionated Radiotherapy for Intermediate-risk Prostate CancerNoelia Sanmamed, Ian Dayes, Charles Catton, et al.
Oral Oncology|September 15, 2019
Treatment outcomes in oropharynx cancer patients who did not complete planned curative radiotherapyFatimah Alfaraj, Tim Craig, Shao Hui Huang, et al.
Diseases of the Colon and Rectum|January 24, 2022
Impact of Definitive Chemoradiation on Quality-of-Life Changes for Patients With Anal Cancer: Long-term Results of a Prospective StudyAli Hosni, Jolie Ringash, Kathy Han, et al.
Oncotarget|May 15, 2018
The ongoing challenge of large anal cancers: prospective long term outcomes of intensity-modulated radiation therapy with concurrent chemotherapyAli Hosni, Kathy Han, Lisa W Le, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 13, 2022
Pan-Canadian consensus recommendations for proton beam therapy access in CanadaGunita Mitera, Derek Tsang, Boyd McCurdy, et al.
International Journal of Radiation Oncology, Biology, Physics|September 8, 2014
Prospective evaluation of acute toxicity and quality of life after IMRT and concurrent chemotherapy for anal canal and perianal cancerKathy Han, Bernard J Cummings, Patricia Lindsay, et al.
Scientific Reports|July 14, 2016
Imaging cervical cytology with scanning near-field optical microscopy (SNOM) coupled with an IR-FELDiane E Halliwell, Camilo L M Morais, Kássio M G Lima, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 25, 2020
Tumor-targeted dose escalation for localized prostate cancer using MR-guided HDR brachytherapy (HDR) or integrated VMAT (IB-VMAT) boost: Dosimetry, toxicity and health related quality of lifeNoelia Sanmamed, Jenny Lee, Alejandro Berlin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 1, 2022
Evaluation of dosimetric predictors of toxicity after IMRT with concurrent chemotherapy for anal cancerJelena Lukovic, Ali Hosni, Amy Liu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 25, 2017
Improved outcomes with dose escalation in localized prostate cancer treated with precision image-guided radiotherapyHamid Raziee, Fabio Y Moraes, Jure Murgic, et al.
European Urology Oncology|May 7, 2025
Patient-reported Quality of Life in PROFIT, a Phase 3 Randomized Clinical Trial Evaluating Moderately Hypofractionated Radiotherapy for Intermediate-risk Prostate CancerNoelia Sanmamed, Ian Dayes, Charles Catton, et al.
Oral Oncology|September 15, 2019
Treatment outcomes in oropharynx cancer patients who did not complete planned curative radiotherapyFatimah Alfaraj, Tim Craig, Shao Hui Huang, et al.
Diseases of the Colon and Rectum|January 24, 2022
Impact of Definitive Chemoradiation on Quality-of-Life Changes for Patients With Anal Cancer: Long-term Results of a Prospective StudyAli Hosni, Jolie Ringash, Kathy Han, et al.
Oncotarget|May 15, 2018
The ongoing challenge of large anal cancers: prospective long term outcomes of intensity-modulated radiation therapy with concurrent chemotherapyAli Hosni, Kathy Han, Lisa W Le, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 13, 2022
Pan-Canadian consensus recommendations for proton beam therapy access in CanadaGunita Mitera, Derek Tsang, Boyd McCurdy, et al.
International Journal of Radiation Oncology, Biology, Physics|September 8, 2014
Prospective evaluation of acute toxicity and quality of life after IMRT and concurrent chemotherapy for anal canal and perianal cancerKathy Han, Bernard J Cummings, Patricia Lindsay, et al.
Scientific Reports|July 14, 2016
Imaging cervical cytology with scanning near-field optical microscopy (SNOM) coupled with an IR-FELDiane E Halliwell, Camilo L M Morais, Kássio M G Lima, et al.
Pageof 8